Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer

This study has been completed.

Study NCT00033462 Information provided by Mayo Clinic

First Received: April 9, 2002 Last Updated: May 4, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2008
Primary Completion Date:	November 2006 (Final data collection date for primary outcome measure)

Publications: